Approval · Notice of Compliance 22166 · 2019
MYOVIEW: Notice of Compliance 22166
Issued May 17, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22166
- Date
- May 17, 2019
- Company
- Ge Healthcare Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Labellling Updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYOVIEW | Not yet assigned | — |
Medicinal ingredients
- TETROFOSMIN 0.23 MG per VIAL